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Surgical Interventions for Renal Cell Carcinoma
with Thrombus Extending into the Inferior Vena
Cava: A Multidisciplinary Approach
Zia Ur Rehman, MBBS, FCPS, ChM,1 M Hammad Ather, MBBS, FCPS, FRCS,2
and Wajahat Aziz, MBBS, FCPS2

Objective: To assess surgical strategies and the impact of a
multidisciplinary approach on patients undergoing inferior
vena caval thrombectomy for renal cell carcinoma and to
evaluate perioperative morbidity and mortality associated
with these procedures.
Methodology: A retrospective audit for all adults who
underwent nephrectomy and inferior vena caval thrombectomy from January 2008 till November 2018 at a University
hospital. Patients with incomplete records were excluded
from the study.
Results: During the study period, 21 patients underwent
inferior vena caval thrombectomy as a completion of radical nephrectomy. Most were males (19 : 2) with a mean age
of 54±11.3 years. The most common surgical approach
was the 11th rib flank approach (n=8) followed by midline
abdominal (n=6) and Mercedes-Benz (n=5). Eight patients
had level 1, 10 patients had level 2, and three patients had
level 3 tumour thrombus. The cavotomy was closed primarily in 20 patients; one required inferior vena cava (IVC)
reconstruction with a pericardial patch. The proximal clamp
was applied below the hepatic veins for most patients. Two
patients required suprahepatic clamping before thrombectomy. There was no intraoperative mortality. Five patients
(24%) developed complications: two required cardiopulmonary resuscitation due to severe hypotension and were
revived; one developed acute renal failure; and one patient
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required a damage control laparotomy for excessive oozing.
There was no thirty-day mortality.
Conclusion: The IVC thrombectomy, along with radical nephrectomy for renal cell carcinoma for 1–3 level thrombus,
can be performed with acceptable morbidity in a multidisciplinary team approach.
Keywords: carcinoma, renal cell, vena cava, inferior, thrombosis

Introduction
In about 4% to 19% of patients with renal cell carcinomas (RCCs), tumours extend into the inferior vena cava
(IVC).1) IVC thrombus in RCC patients has a signiﬁcant
adverse impact on the overall prognosis. Surgical extirpation of both renal tumour and IVC is the standard treatment option. Performing tumour thrombectomy in the
IVC is associated with better outcomes in this subgroup
of patients.2) Since there are few alternative management
options, like systemic therapy and radiotherapy, aggressive surgical removal of the tumour and thrombus remains
the primary option for patients.3,4) Current evidence does
not associate a higher level of thrombus with accelerated
tumour dissemination to lymphatics in the perinephric fat
or distantly. Preoperative embolization is associated with
increased morbidity,5) and use of IVC ﬁlters remains uncertain. The best approach for surgical treatment of these
patients remains unclear. The study objectives are to assess
surgical strategies for patients undergoing IVC thrombectomy for renal cell carcinoma with thrombus extending
into the IVC and to evaluate associated perioperative
morbidity and mortality.

Methodology
We conducted a retrospective audit of adult patients (>18
years) who underwent tumour nephrectomy and IVC tumour removal at a University hospital from January 2008
through November 2018. The Institutional Review Board
granted an exemption for this study (2018-0583-568). All
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patients had surgery performed under general anesthesia.
Computed tomography (CT) of the abdomen was performed before surgery, and the tumours were classiﬁed
into four categories, according to the cranial extension
of the thrombus into the IVC, as described by Neves and
Zincke.6) The patients were approached through midline,
subcostal, chevron or Mercedes-Benz incisions, depending
on patient habitus, tumour size, tumour thrombus level,
and surgeon experience. The speciﬁc surgical technique
was selected on the thrombus extension level. This also
guided the surgical approach and teams to be involved.
We had excellent communication with anesthesia and the
blood bank teams. For level 1 and 2 tumour thrombus,
both the urology and vascular surgery teams usually work
in tandem for minimal IVC handling until the proximal
extent is deﬁned and controlled. For a level 1 tumour,
a cavotomy was performed and the tumour removed
after control of the proximal and distal vena cava and
contralateral renal vein. If the tumour were limited to the
renal vein, a tumour thrombectomy was performed, with
little dissection, after applying only a side-biting clamp.
Primary repair was performed if there were no signiﬁcant
vein defect; if there were, patch repair was considered. For
a level 2 tumour, IVC control above the thrombus was
more difﬁcult; it required hepatic mobilization in case of
retrohepatic extension. After getting control of the infrarenal IVC, contralateral renal vein, and supra renal IVC,
the tumour thrombus was removed en bloc if possible. For
level 3 tumours, the hepatic surgery team was involved.
The same control was achieved, but the proximal clamp
was applied to the suprahepatic area. The patient was
placed in the reverse Trendelenburg position. The liver
was rolled to the patientʼs left, and the IVC was opened
along the anterolateral aspect to the level of the hepatic
veins. After complete hepatic mobilization, the supra hepatic IVC, infra renal IVC, contralateral renal vein, and
hepatoduodenal ligaments were occluded sequentially
to perform the thrombectomy in a bloodless ﬁeld. The
surgical team would then complete the nephrectomy and
remove the specimen. The thrombus was removed en bloc
through longitudinal cavotomy, but in some instances, it
adhered to the wall and was removed piecemeal. Every effort was made to ensure there was no residual thrombus in
the proximal portion by back bleeding before ﬁnal closure
of the cavotomy. To prevent air embolism, the patient was
placed in a Trendelenburg position for back bleeding from
the proximal end.
Patients with incomplete follow-up or incomplete records were excluded from the study. All the data were
collected retrospectively from patientsʼ medical records
on specially designed proforma. The data included patient
demographics, comorbidities, tumour thrombus levels, incision for exposure, surgical strategy use, total blood loss
56

(ml), total operative time (h), intensive care unit (ICU) stay
(days), total hospital stay (days), perioperative morbidity
and mortality.
The data was analyzed on SPSS version 20.0 (IBM
Corp., Chicago, IL, USA). Descriptive statistics were reported for the quantitative variable as mean±standard
deviation (SD)/Median (interquartile range [IQR]) and for
categorical variables was reported as frequency (%).
The outcome measures were mortality (intraoperative
or within 30 days postoperatively), morbidity, ICU stay,
and blood loss.

Results
During the study period, 21 patients underwent IVC
thrombectomy to complete the radical nephrectomy
(Table 1). Most were males (19 : 2) with a mean age of 54
(SD±11.3) years. The most common surgical approach
was the 11th rib retroperitoneal/extra pleural approach
(n=8) followed by midline (n=6) and Mercedes-Benz
(n=5). Eight patients had a level 1, 10 patients had a level
2, and three patients had a level 3 tumour extension. No
patients had tumour extension into the right atrium. The
most common procedure was radical nephrectomy and
IVC thrombectomy with primary closure. In one patient,
IVC was reconstructed with a pericardial patch (Table 1).
Table 1 Basic demographic data, surgical approaches employed, IVC closure technique and vascular control
technique
n=21
Mean age (years) (±SD)

54.8 (±11.3)

Gender (male : female)

19 : 2

Side of tumour (right : left)

18 : 3

Level of tumour thrombus
Level 1

8 (35%)

Level 2

10 (50%)

Level 3

3 (15%)

Level 4

0 (0%)

Surgical approaches
Midline

6 (30%)

Subcostal

8 (35%)

Mercedes-Benz

5 (25%)

Thoracoabdominal

1 (5%)

Chevron

1 (5%)

IVC reconstruction
Primary closure
Patch closure of IVC

20 (95%)
1 (5%)

Level of proximal clamping
a. Sub hepatic

14 (70%)

b. Retro hepatic below hepatic veins

4 (20%)

c. Supra hepatic

2 (10%)

IVC: inferior vena cava; SD: standard deviation
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Distant metastasis was identiﬁed in four patients preoperatively. The proximal clamp was placed below the hepatic
veins except for two patients who required suprahepatic
clamping before thrombectomy (Table 1). Nephrectomy
was performed ﬁrst with ligation and division of the renal
artery and vein; the kidney was removed for better access. After exposure and clamping of the IVC, the tumour
thrombi were removed through an anterior cavotomy.
The mean operative blood loss was 2,893 ml (±2,447).
The mean operative time was 4.5 h (Table 2). There was
no intraoperative mortality. Two patients required cardioTable 2 Outcome variables showing total blood loss, mean
operative time (from incision to wound closure), total
hospital stay, ICU stay and different complications

pulmonary resuscitation (CPR) due to severe hypotension
and were revived. One patient developed acute kidney
injury; however, it resolved with conservative treatment.
One patient with a relatively larger renal tumour developed hypothermia and coagulopathy at the end of the
operation. There was excessive oozing from the dissection
bed. The patient required a damage control laparotomy
and the abdomen was closed after 48 h (Table 2). Most
of the tumour thrombectomies were accomplished via the
11th rib approach, which was common for level 1 tumour
thrombus, while the Mercedes-Benz was used for level 3
tumours (P-value=0.02) (Table 3).
More blood loss tended to occur with increased tumour
thrombus levels. Higher tumour thrombus levels were also
associated with longer operation times (Table 4).

Variables n=21
Total estimated blood loss (ml) (±SD)

2893 (±2447)

Total operative time (h) (±SD)

4.7 (±1.4)

Total hospital stay (days) (±SD)

8.3 (±3.61)

Mean ICU stay (days)

4.5

Perioperative complications
Pulmonary embolism

1

Acute renal failure

1

Severe intraoperative hypotension
(requiring CPR)

2

Severe hypothermia

1

30-day mortality

0

ICU: intensive care unit; SD: standard deviation; CPR: cardiopulmonary resuscitation

Discussion
The American Cancer Societyʼs most recent estimates for
kidney cancer in the United States indicate there were
nearly 63,340 new cases of kidney cancer (42,680 in men
and 22,660 in women) in 2018. Approximately 14,970
people (10,010 men and 4,960 women) will die from
this disease.7) RCC has a biological predisposition for
direct vascular invasion. Intravascular tumour thrombus
is found in 10%–40% of patients with RCC in the renal
vein or IVC.8) IVC thrombus is a poor prognostic indicator, with a life expectancy of less than six months in
untreated cases.9) A radical nephrectomy and cava throm-

Table 3 Different surgical approaches, proximal clamping, perioperative complications, and ICU stay between different thrombus levels
Level 1

Level 2

Level 3

(n=8)

(n=10)

(n=3)

Male

8 (100%)

8 (80%)

3 (100%)

0.632

Right sided of tumour

7 (100%)

8 (80%)

3 (100%)

0.632

a. Subcostal

7 (90%)

1 (10%)

0 (0.0%)

Variables

P-value

Surgical approaches

0.022

b. Mercedes-Benz

0 (0.0%)

3 (30%)

2 (66.7%)

Suprahepatic clamping

0 (0.0%)

0 (0.0%)

2 (66.7%)

0.016

Perioperative complications

1 (14.3%)

1 (10%)

2 (66.6%)

0.06

ICU stay (days)

0 (0.0%)

3 (30%)

3 (99.9%)

0.03

T3 N0 Mx

5 (71.4%)

7 (70%)

1 (33.3%)

0.355

ICU: intensive care unit
Table 4 Differences in total blood loss (ml), total operative time (h) and total hospital stay (days) between different levels of tumour
thrombus

Total EBL (median) (IQR)
Total operative time (h) (median) (IQR)

Level 1

Level 2

Level 3

(n=3)

(n=10)

(n=3)

1,000 (670–1,800)

2,250 (1,500–6,250)

4,000 (1,500–4,000)

3.75 (3.00–5.00)

5.25 (4.37–6.00)

6 (5.00–7.00)

8 (6.5–12.00)

Total hospital stay (days) (median) (IQR)

5.50 (4.1–5.00)
10 (7.00–10.00)

P-value
0.07
0.134
0.055

EBL: estimated blood loss; IQR: interquartile range

Annals of Vascular Diseases Vol. 12, No. 1 (2019)

57

Rehman ZU, et al.

bectomy is one of the most potent management strategies
associated with long-term survival. Radical extirpative
surgery, with nephrectomy and IVC thrombectomy, only
provides medium term survival.10) In a recently reported
large series, Master et al.11) noted that resection of RCC
with IVC tumour thrombus yields long-term survival.
Haferkamp et al.12) noted that patients with metastatic
disease, IVC thrombus, and RCC have better survival with
surgical extirpation followed by tyrosine kinase inhibitors
(TKI). For RCC patients without distal metastases who
undergo radical nephrectomy and IVC tumour thrombectomy, the ﬁve-year survival rate has been reported to
be 45%–69%.13) Temporary ﬁlters and liver mobilization
techniques improve the safety and prognosis of radical nephrectomy and IVC thrombectomy in renal cell carcinoma
with subdiaphragmatic thrombosis.
Berg was the ﬁrst to report nephrectomy and cavotomy
to treat RCC with tumour thrombus extending into the
IVC.14) Since Bergʼs ﬁrst report, radical nephrectomy with
vena cavotomy has become a safe and effective treatment
for RCC with IVC thrombus. The 30-day mortality for
radical nephrectomy with IVC thrombectomy has been
reported to be 1.5%–10%, and the complication rates
have been reported to be 18%, 20%, 26%, and 47%
for IVC tumour thrombus level I, II, III, and IV disease,
respectively.15) Fortunately there was no 30-day mortality
in our series. The complication rate is 30%, which is comparable to the contemporary series. We consider this to
our multidisciplinary approach. Most of the patients with
level 1 were approached through ﬂank or subcostal incision. This depended on the individual tumour size and the
surgeon choice. If the tumour thrombus was higher, wider
incisions were used. More patients were approached via
Mercedes-Benz or chevron incisions. The wider exposure
did help complete this radical procedure safely. Although
level 1 tumours do not require any complex maneuvers,
except for control of the IVC above and below the tumour,
level 2 and 3 tumours require more complex maneuvers.
There was a patient in with level 1 who had catastrophic
bleeding while undergoing dissection around the renal
vein. He ended up in acute renal failure. This highlights
the practical difﬁculty while dissecting around these tumours when the natural planes are lost, tissues are thick,
and the hyperemic anatomy is distorted. Getting adequate
exposure was always helpful.
One of the challenges is managing these patientsʼ hemodynamic disturbances as they undergo thrombectomies.
Whereas temporary occlusion of the infrahepatic IVC can
be safely be done for level 1 tumours, the occlusion of
the suprahepatic IVC often causes a profound decrease in
venous return, resulting in hypotension. Before applying
clamps, patients were well hydrated and were hemodynamically stabilized. There was also a check of clamping,
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for a minute, for hemodynamic disturbances before proceeding to cavotomy. There are various ways, described
during IVC thrombectomy and nephrectomy, to prevent
intraoperative hypotensive shock and pulmonary embolism. These include veno-venous bypass, cardiopulmonary
bypass, and deep hypothermic circulatory arrest. However, there are alternate ways to control vessels, including
IVC and hepatic pedicle sufﬁces. In a recent report Chen
et al.16) showed the safety of treating level III IVC, concomitant to RCC, by precisely controlling IVC and hepatic
vessels without a vascular bypass.
Two patients had severe hypotension after proximal
clamp application, but were revived with brief cardiopulmonary resuscitation. The various strategies mentioned in
literature to deal with these hemodynamic changes, from
proximal clamping as veno-venous bypass, were backup
strategies for our patients. None of them required it. We
retrospectively think that using these strategies proactively
would have avoided these hemodynamic changes.
Renal tumours often invade the vena cava wall, regardless of thrombus level.17) One patient with this invasion
required IVC reconstruction with a pericardial patch.
The median blood loss in this case series ranges from
1,000 ml for level 1 to 4,000 ml for level 3. This signiﬁes
need to continuously resuscitate these patients intraoperatively. We also employed damage-controlled strategies
when needed in an occasional patient. As mentioned, one
patient had level 2 thrombi. During dissection for the
nephrectomy and thrombectomy, the patient experienced
oozing and was on the verge of becoming hypothermic at
the end of operation. It was decided to temporarily pack
the abdomen and resuscitate the patient in the ICU. The
patient was revived and returned to the operating room
after 48 h for removal of packs and deﬁnitive closure of
the abdomen.
One of our patients had a pulmonary embolus that was
not present before surgery. The embolus was suspected
on a routine postoperative chest X-ray and subsequently
conﬁrmed on chest CT. Indeed, pulmonary metastases
from IVC thrombus are not well highlighted in the literature. The follow-up of this patient indicated multiple
lung metastatic deposits in a scan three months after IVC
thrombectomy. Soon after the surgery he was placed on
TKI. Pulmonary embolism is indeed a devastating complication caused by tumour thrombus shedding due the
manipulation of the IVC during surgery; the mortality rate
could be up to 75%.18)
For high-risk patients, the European Association for
Urology (EAU) guidelines recommend the ﬁrst CT six
months after surgery and, subsequently, once a year up to
three years and every two years afterwards. A recent report by Elahmadawy et al.,19) about detection of local and
distant disease relapse in surgically treated patients with
Annals of Vascular Diseases Vol. 12, No. 1 (2019)
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RCC, indicated that local and/or distant disease relapse
was conﬁrmed in 72% of patients. Regarding local recurrence, ﬂuorodeoxyglucose positron emission tomographycomputed tomography (FDG PET-CT) showed speciﬁcity
of 100%, compared to 98.6% with contrast-enhanced CT
(P>0.05) and higher sensitivity noted with contrast-enhanced CT (100%) compared to 96% with FDG PET-CT.
The limitations of this study are that it is retrospective and from a single institute. Despite these limitations,
it appears to be safe to perform an IVC thrombectomy
with a multidisciplinary approach in a developing world
university.

Conclusion
The IVC thrombectomy, along with radical nephrectomy
for renal cell carcinoma, can be performed with acceptable
morbidity and mortality in level 1 to 3 tumour thrombus
extension.
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